Hugh Gannon

KSQ Therapeut

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 29 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Figure S4 from the USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

Louise Cadzow,Jehrod Brenneman,Erica Tobin,Pamela Sullivan,Sumeet Nayak,Janid A. Ali,Sol Shenker,Jim Griffith,Michael McGuire,Paula Grasberger,Yuji Mishina,Morgan Murray,Anne E. Dodson,Hugh Gannon,Elsa Krall,Jeff Hixon,Edmond Chipumuro,Kerstin Sinkevicius, Prafulla C. Gokhale,Suthakar Ganapathy,Ursula A. Matulonis,Joyce F. Liu,Andrew Olaharski,Dipen Sangurdekar, Hanlan Liu,Jeremy Wilt,Michael Schlabach,Frank Stegmeier,Andrew A. Wylie

crossref（2024）

引用0浏览0引用

Figure S1 from the USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

crossref（2024）

引用0浏览0引用

Abstract 20: KSQ-001EX: An engineered TIL therapy manufactured from a clinical-scale, feeder-free process for the treatment of solid tumor indications

Sharon Lin, Gustavo Martinez,Marie-Andrée Forget, Katrina Adlerz,Mitali Ghose,Leila Williams,Paul Dunbar, Frank Thompson,Fiona Sharp,Hugh Gannon,Conor Calnan,Ashish Yeri,Dipen Sangurdekar, Donald Sakellariou-Thompson,Samantha Fix, Tamara Griffith, Ellie Jafari, Jane Zulovich,Priya Balasubramanian,Erin Willert,MIcah Benson,Chantale Bernatchez,Karrie Ka Wai Wong

Cancer Researchno. 6_Supplement (2024): 20-20

引用0浏览0引用

Figure S9 from the USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

Louise Cadzow,Jehrod Brenneman,Erica Tobin,Pamela Sullivan,Sumeet Nayak,Janid A. Ali,Sol Shenker,Jim Griffith,Michael McGuire,Paula Grasberger,Yuji Mishina,Morgan Murray,Anne E. Dodson,Hugh Gannon,Elsa Krall,Jeff Hixon,Edmond Chipumuro,Kerstin Sinkevicius,Prafulla C. Gokhale,Suthakar Ganapathy,Ursula A. Matulonis,Joyce F. Liu,Andrew Olaharski,Dipen Sangurdekar, Hanlan Liu,Jeremy Wilt,Michael Schlabach,Frank Stegmeier,Andrew A. Wylie

crossref（2024）

引用0浏览0引用

Supplementary Table 2 from the USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

crossref（2024）

引用0浏览0引用

Figure S5 from the USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

crossref（2024）

引用0浏览0引用

Supplementary Table 3 from the USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

crossref（2024）

引用0浏览0引用

The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors

Louise Cadzow,Jehrod Brenneman,Erica Tobin,Pamela Sullivan,Sumeet Nayak,Janid A. Ali,Sol Shenker,Jim Griffith,Michael McGuire,Paula Grasberger, Yuji Mishina,Morgan Murray,Anne E. Dodson,Hugh Gannon,Elsa Krall,Jeff Hixon,Edmond Chipumuro,Kerstin Sinkevicius,Prafulla C. Gokhale,Suthakar Ganapathy,Ursula A. Matulonis,Joyce F. Liu,Andrew Olaharski,Dipen Sangurdekar,Hanlan Liu,Jeremy Wilt,Michael Schlabach,Frank Stegmeier,Andrew A. Wylie

CANCER RESEARCHno. 20 (2024): 3419-3434

引用0浏览0WOS引用

Figure S6 from the USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

Louise Cadzow,Jehrod Brenneman,Erica Tobin,Pamela Sullivan,Sumeet Nayak,Janid A. Ali,Sol Shenker,Jim Griffith,Michael McGuire,Paula Grasberger,Yuji Mishina,Morgan Murray,Anne E. Dodson,Hugh Gannon,Elsa Krall,Jeff Hixon,Edmond Chipumuro,Kerstin Sinkevicius,Prafulla C. Gokhale,Suthakar Ganapathy,Ursula A. Matulonis,Joyce F. Liu,Andrew Olaharski,Dipen Sangurdekar, Hanlan Liu,Jeremy Wilt,Michael Schlabach,Frank Stegmeier,Andrew A. Wylie

crossref（2024）

引用0浏览0引用

Figure S8 from the USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

crossref（2024）

引用0浏览0引用

加载更多

作者统计

#Papers: 29

#Citation: 170

H-Index: 4

G-Index: 7

Sociability: 5

Diversity: 1

Activity: 10

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn